158 related articles for article (PubMed ID: 23238898)
41. Primary diffuse large B-cell lymphoma of the mandible. A case report.
Pié-Sánchez J; Petit J; Figueiredo R; Gay-Escoda C
Minerva Stomatol; 2011; 60(1-2):87-92. PubMed ID: 21252853
[TBL] [Abstract][Full Text] [Related]
42. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
Jerkeman M; Anderson H; Dictor M; Kvaløy S; Akerman M; Cavallin-Ståhl E;
Ann Hematol; 2004 Jul; 83(7):414-9. PubMed ID: 15085385
[TBL] [Abstract][Full Text] [Related]
43. The impact of age, Charlson comorbidity index, and performance status on treatment of elderly patients with diffuse large B cell lymphoma.
Lin TL; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Tang TC; Chang H; Hung YS
Ann Hematol; 2012 Sep; 91(9):1383-91. PubMed ID: 22526364
[TBL] [Abstract][Full Text] [Related]
44. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM
Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432
[TBL] [Abstract][Full Text] [Related]
45. [Standard or up-to-date treatment for high risk, relapsed and refractory DLBCL].
Kagami Y
Rinsho Ketsueki; 2010 Oct; 51(10):1409-16. PubMed ID: 20962474
[No Abstract] [Full Text] [Related]
46. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
Frick M; Dörken B; Lenz G
Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
[TBL] [Abstract][Full Text] [Related]
47. Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL.
Suzuki Y; Yoshida T; Wang G; Togano T; Miyamoto S; Miyazaki K; Iwabuchi K; Nakayama M; Horie R; Niitsu N; Sato Y; Nakamura N
Ann Hematol; 2012 Jul; 91(7):997-1005. PubMed ID: 22249209
[TBL] [Abstract][Full Text] [Related]
48. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
49. Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20(+) B-cell lymphomas.
Achenbach M; Bittenbring JT; Ziepert M; Regitz E; Ott G; Rosenwald A; Pfreundschuh M; Altmann B; Held G
Br J Haematol; 2014 Nov; 167(3):430-4. PubMed ID: 24974897
[No Abstract] [Full Text] [Related]
50. Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation.
Hung MH; Yu YB; Huang YC; Liu HT; Hong YC; Hsiao LT; Liu JH; Gau JP; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Ann Hematol; 2012 Dec; 91(12):1907-15. PubMed ID: 22885989
[TBL] [Abstract][Full Text] [Related]
51. High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma.
Marchesi F; Cirillo M; Bianchi A; Gately M; Olimpieri OM; Cerchiara E; Renzi D; Micera A; Balzamino BO; Bonini S; Onetti Muda A; Avvisati G
Hematol Oncol; 2015 Jun; 33(2):110-2. PubMed ID: 24711044
[No Abstract] [Full Text] [Related]
52. Primary colonic lymphoma: an analysis of 74 cases with localized large-cell lymphoma.
Tang TC; Kuo MC; Chang H; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Kuo TT; Shih LY
Eur J Haematol; 2011 Jul; 87(1):28-36. PubMed ID: 21535155
[TBL] [Abstract][Full Text] [Related]
53. The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab.
Benesova K; Forsterova K; Votavova H; Campr V; Stritesky J; Velenska Z; Prochazka B; Pytlik R; Trneny M
Neoplasma; 2013; 60(1):68-73. PubMed ID: 23067219
[TBL] [Abstract][Full Text] [Related]
54. [Salvage gastrectomy and radiotherapy for R-CHOP-refractory gastric malignant lymphoma].
Shibata S; Akasaka H; Wakiya T; Yamanaka Y; Narita J; Sutou T; Iino C
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2396-8. PubMed ID: 25731535
[TBL] [Abstract][Full Text] [Related]
55. Rapid bone marrow dissemination after surgery in localized gastric diffuse large B-cell lymphoma: a case report.
Isoda A; Hatsumi N; Ogawa Y; Matsumoto M; Sawamura M
Int J Hematol; 2006 Dec; 84(5):471-2. PubMed ID: 17189234
[No Abstract] [Full Text] [Related]
56. Prognostic models for diffuse large B-cell lymphoma.
Conconi A; Zucca E; Roggero E; Bertoni F; Bernasconi A; Mingrone W; Pedrinis E; Cavalli F
Hematol Oncol; 2000 Jun; 18(2):61-73. PubMed ID: 10960876
[TBL] [Abstract][Full Text] [Related]
57. Diffuse large B-cell lymphoma with a bulky mass in the cranial vault.
Kanaya M; Endo T; Hashimoto D; Endo S; Takemura R; Okada K; Hatanaka KC; Matsuno Y; Teshima T
Int J Hematol; 2017 Aug; 106(2):147-148. PubMed ID: 28390034
[No Abstract] [Full Text] [Related]
58. Vincristine-induced blindness: a case report and review of literature.
Adhikari S; Dongol RM; Hewett Y; Shah BK
Anticancer Res; 2014 Nov; 34(11):6731-3. PubMed ID: 25368282
[TBL] [Abstract][Full Text] [Related]
59. Primary thyroid lymphoma.
Ríos A; Rodríguez JM; Febrero B; Parrilla P
Endocrinol Nutr; 2014 Nov; 61(9):497-9. PubMed ID: 24935697
[No Abstract] [Full Text] [Related]
60. Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.
Meissner J; Finel H; Dietrich S; Boumendil A; Kanfer E; Laboure G; Abecasis M; Cornelissen J; Delage J; Finke J; Hess U; Ludwig H; Mohty M; Pabst T; Pioltelli P; Robinson S; Samaras P; Montoto S; Dreger P
Bone Marrow Transplant; 2017 Apr; 52(4):650-652. PubMed ID: 27991887
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
